Stockscreener 앱 받기
0.9176
2.90%
0.0259
시간 외 거래:
.94
0.0224
+2.44%
전일 마감가:
$0.8917
열려 있는:
$0.88
하루 거래량:
129.65K
Relative Volume:
0.16
시가총액:
$2.07M
수익:
$71.39M
순이익/손실:
$-28.60M
주가수익비율:
-0.2453
EPS:
-3.74
순현금흐름:
$-12.92M
1주 성능:
+30.26%
1개월 성능:
+22.35%
6개월 성능:
+10.71%
1년 성능:
-64.30%
1일 변동 폭
$0.88
$0.9269
1주일 범위
$0.7133
$0.9269
52주 변동 폭
$0.48
$3.39
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
TRIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.9176 | 15.47M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-10-23 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2015-09-03 | 개시 | Raymond James | Outperform |
| 2015-07-29 | 재확인 | ROTH Capital | Buy |
| 2008-07-22 | 재확인 | Roth Capital | Buy |
| 2008-03-17 | 재확인 | Roth Capital | Buy |
| 2007-12-10 | 재확인 | Roth Capital | Buy |
| 2007-10-26 | 재확인 | Roth Capital | Buy |
모두보기
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com India
Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service - GlobeNewswire Inc.
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com India
Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech regains Nasdaq compliance - Investing.com
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com India
North America Blood Testing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Blood Testing Market Size & Outlook, 2030 - Grand View Research
Germany Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Global Blood Testing Market Size & Outlook, 2024-2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Trinity Biotech to Implement ADS Ratio Change By Investing.com - Investing.com India
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo - Yahoo Finance
TRIB News Today | Why did Trinity Biotech stock go up today? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Investors in health-care stocks get rich as M&A booms - MarketWatch
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling - Insider Monkey
Trinity Biotech Plc Adr (TRIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):